Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ)

18,28 +0,15 (+0,83%) Alla chiusura: 03:04PM CST

Hefei Lifeon Pharmaceutical Co., Ltd.

Cube Factory
No. 669 Changjiang West Road
Hefei 230088
China
86 551 6535 0389
https://www.lifeonapi.com

Settore/i: Healthcare
Settore: Biotechnology
Impiegati a tempo pieno: 1.315

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Ms. Xiaojuan Deng	Vice Chairman of the Board & GM	N/D	N/D	1965
Mr. Shaobing Gou	Financial Director	N/D	N/D	1977
Mr. Xueyu Xu	Deputy General Manager	N/D	N/D	1964
Mr. Jun Chen	R&D Director & Non-Independent Director	N/D	N/D	1963
Mr. Tianhe Dai	Deputy General Manager	N/D	N/D	1977
Mr. Jun Xia	Deputy GM & Secretary of the Board	N/D	N/D	1983
Ms. Qing Wang	Deputy GM & Non-Independent Director	N/D	N/D	1967
Mr. Huanxi Cui	General Manager	N/D	N/D	1979

Gli importi risalgono al giorno e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in CNY.

Descrizione

Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients. It operates through Pharmaceutical Industry, Pharmaceutical Wholesale and Distribution, and Pharmaceutical Retail Business segments. The company offers active pharmaceutical ingredients, which include nifedipine, paliperidone, prilocaine, methylphenidate hydrochloride, dimercaptosuccinic acid, doxazosin mesylate, paeonol, urea, felodipine, and troxerutin; and medical preparations, such as osmotic pump preparations, central nervous systems, Chinese patent medicines, eye drops, external use, and general oral medicines. In addition, it provides medical intermediates, including 3-methoxy-1 propanethiol, mercaptosuccinic acid, domiphene, sodium dimercaptosulfonate, 3-mercapto-1-propanol, paeonol, sodium paeonol sulfonate, methyl 2,3-dichlorobenzylidene acetoacetate, n-[(1,4-benzodioxan-2-yl) carbonyl piperazine hydrochloride, alogliptin benzoate, roflumilast, and zofenopril calcium; plant extract products, such as clove oil and campanula extracts; and pieces that consist of poria decoction, astragalus, honeysuckle, rose, and phellinus decoction. Further, the company offers central nervous system drugs, cardiovascular drugs, digestive system drugs, ophthalmic drugs, external skin drugs and other fields. Hefei Lifeon Pharmaceutical Co., Ltd. was founded in 2002 and is headquartered in Hefei, China.

Governance aziendale

L'ISS Governance QualityScore di Hefei Lifeon Pharmaceutical Co., Ltd. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.